The miracle cure with a billion-dollar price tag

It's been hailed as a miracle cure for hepatitis C – but comes with a billion-dollar price tag. ...

Read more →

PBS listing with strings for melanoma drug

Breakthrough melanoma drug Keytruda has been recommended for a restricted listing on the Pharma­ceutical Benefits Scheme, amid a sombre warning ...

Read more →

Hepatitis C treatments: Australia urged to subsidise 'revolutionary' new drugs

[:content [\1 \5 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \P \u \b \l \i \c \space \h \e \a \l \t \h \space \e \x \p \e \r \t \s \space \s \a \y \space \e \f \f \e \c \t \i \v \e \space \n \e \w \space \d \r \u \g \s \space \t \o \space \t \r \e \a \t \space \h \e \p \a \t \i \t \i \s \space \C \space \s \h \o \u \l \d \space \b \e \space \s \u \b \s \i \d \i \s \e \d \space \i \n \space \A \u \s \t \r \a \l \i \a \space \t \o " ..."]]
Read more →

Indicative 1 April 2015 prices - 2015 April cycle

Indicative 1 April 2015 prices resulting from the 2015 April cycle of price disclosure have now been published on the ...

Read more →

Divestment of portfolio of branded and generic products to Strides entities

Aspen is pleased to announce that certain of its wholly owned Australian subsidiaries (collectively “Aspen Australia”), have entered into an ...

Read more →

Medicines scheme overhaul raises health concerns

[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \  " ..."]]
Read more →

Confirmation of 1 October 2014 price disclosure prices

Confirmation of 1 October 2014 new PBS prices resulting from the 2014 October cycle have been published on the price ...

Read more →

Ron Walker's cancer crusade pays dividends

Ron Walker's campaign to turn a $150,000-a-year cancer drug into an accessible treatmenthas paid off, with the federal government deciding to list Keytruda on ...

Read more →

PBS changes: drug prices to drop, push for generics

Consumers will pay up to 50 per cent less for many common medicines under changes to the Pharmaceutical Benefits Scheme ...

Read more →

PBS mobile website

[:content [\2 \4 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \A \space \s \m \a \r \t \space \p \h \o \n \e \space \a \n \d \space \t \a \b \l \e \t \space \v \e \r \s \i \o \n \space \o \f \space \t \h \e \space \P \B \S \space \w \e \b \s \i \t \e \space \i \s \space \n \o \w \space \a \v \a \i \l \a \b \l \e \. \space \U \s \e \r \s \space \o \f \space \m \o \b \i \l \e \space \d \e \v \i \c \e \s " ..."]]
Read more →

Agenda for the July 2015 PBAC meeting

The agenda for the July 2015 PBAC meeting is now available on the PBS website. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 January 2015 update

The January 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The Schedule includes the ...

Read more →

Fact Sheets - Administration, Handling and Infrastructure fee & Premium Free Dispensing Incentive

Fact sheets on the administration, handling and infrastructure fee, premium free dispensing incentive and adjusted tier 2 pricing have been ...

Read more →

Australia breaks with biologic prescribers, other regulators on biosimilar substitution

The Alliance for Safe Biologic Medicines (ASBM) today condemned recent announcements by Australian Health Minister Sussan Ley and the Pharmaceutical Benefits Advisory Committee (PBAC) ...

Read more →

NICE gives the green light to aflibercept (Eylea) for patients with wet AMD in final guidance

[:content [\N \I \C \E \space \h \a \s \space \p \u \b \l \i \s \h \e \d \space \f \i \n \a \l \space \g \u \i \d \a \n \c \e \space \r \e \c \o \m \m \e \n \d \i \n \g \space \t \h \e \space \u \s \e \space \o \f \space \a \f \l \i \b \e \r \c \e \p \t \  \a \s \space \a \n \space \o \p \t \i \o \n \space \f \o \r \space \t \r \e \a \t \i \n \g \space \p \a \t \i \e \n \t \s \space \w \i \t \h \  \w \e \t \space \a \g \e \- \r \e \l \a \t \e \d \space \m \a \c \u \l \a \r \space \d \e \g \e \n \e \r \a \t \i \o \n \space \( \A \M \D \) \. \  \A \f \l \i \b \e \r \c \e \p \t " ..."]]
Read more →